Enoxaparin dominates UFH for acute coronary syndromes in Poland

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.419, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin: An Update of its Clinical Use in the Management of Acute Coronary Syndromes

By Ibbotson T.   Goa K.L.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1407-1430

Adis International

Access to resources Recommend Favorite

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M   Mahaffey Kenneth W  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

By Balen R.M.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Enoxaparin: A Pharmacoeconomic Review of its Use in the Prevention and Treatment of Venous Thromboembolism and in Acute Coronary Syndromes

By Bergqvist D.  

PharmacoEconomics, Vol. 20, Iss. 4, 2002-04 ,pp. : 225-243

Adis International

Access to resources Recommend Favorite

Fondaparinux in acute coronary syndromes

By Chaturvedi Vivek   Karthikeyan Ganesan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1615-1623

Informa Healthcare

Access to resources Recommend Favorite